Biomarkers for major depression and its delineation from neurodegenerative disorders

Progress in Neurobiology

Volumn 95, Issue 4, 2011, Pages 703-717

  Schneider, Barbara ^a   Prvulovic, David ^a   Oertel Knöchel, Viola ^a   Knöchel, Christian ^a   Reinke, Britta ^a   Grexa, Martin ^a   Weber, Bernhard ^a   Hampel, Harald ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Adult neurogenesis; Cognitive decline; Major depression; Neurodegenerative disorders; Neuroimaging findings; Neurotrophic factors

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; COGNITIVE DEFECT; COMORBIDITY; DEGENERATIVE DISEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; NEUROPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; DEPRESSIVE DISORDER; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; NERVE GROWTH FACTORS; NEUROCHEMISTRY; NEURODEGENERATIVE DISEASES; NEUROIMAGING; PITUITARY-ADRENAL SYSTEM;

EID: 82755197814     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2011.08.001     Document Type: Review

References (213)

1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., Snyder P.J., Carrillo M.C., Thies B., Phelps C.H. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:270-279.
2. Alexopoulos G.S., Meyers B.S., Young R.C., Mattis S., Kakuma T. The course of geriatric depression with "reversible dementia": a controlled study. Am. J. Psychiatry 1993, 150:1693-1699.
3. Alexopoulos G.S., Young R.C., Meyers B.S. Geriatric depression: age of onset and dementia. Biol. Psychiatry 1993, 34:141-145.
4. Altar C.A., Whitehead R.E., Chen R., Wortwein G., Madsen T.M. Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry 2003, 54:703-709.
5. Anand A., Li Y., Wang Y., Lowe M.J., Dzemidzic M. Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression. Psychiatry Res. 2009, 171:189-198.
6. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol. Psychiatry 2005, 57:1079-1088.
7. Anand A., Li Y., Wang Y., Wu J., Gao S., Bukhari L., Mathews V.P., Kalnin A., Lowe M.J. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology 2005, 30:1334-1344.
8. Andersen K., Lolk A., Kragh-Sorensen P., Petersen N.E., Green A. Depression and the risk of Alzheimer disease. Epidemiology 2005, 16:233-238.
9. Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E., Blennow K. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol. 1999, 56:673-680.
10. Angelucci F., Spalletta G., di I.F., Ciaramella A., Salani F., Colantoni L., Varsi A.E., Gianni W., Sancesario G., Caltagirone C., Bossu P. Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients are characterized by increased BDNF serum levels. Curr. Alzheimer Res. 2010, 7:15-20.
11. Auer D.P., Putz B., Kraft E., Lipinski B., Schill J., Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol. Psychiatry 2000, 47:305-313.
12. Aydemir O., Deveci A., Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:261-265.
13. Baaré W.F., Vinberg M., Knudsen G.M., Paulson O.B., Langkilde A.R., Jernigan T.L., Kessing L.V. Hippocampal volume changes in healthy subjects at risk of unipolar depression. J. Psychiatr Res. 2010, 44:655-662.
14. Bachevalier J., Loveland K.A. The orbitofrontal-amygdala circuit and self-regulation of social-emotional behavior in autism. Neurosci. Biobehav. Rev. 2006, 30:97-117.
15. Baghai T.C., Binder E.B., Schule C., Salyakina D., Eser D., Lucae S., Zwanzger P., Haberger C., Zill P., Ising M., Deiml T., Uhr M., Illig T., Wichmann H.E., Modell S., Nothdurfter C., Holsboer F., Muller-Myhsok B., Moller H.J., Rupprecht R., Bondy B. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression. ACE activity and hypercortisolism. Mol. Psychiatry 2006, 11:1003-1015.
16. Ballard C., Bannister C., Solis M., Oyebode F., Wilcock G. The prevalence, associations and symptoms of depression amongst dementia sufferers. J. Affect. Disord. 1996, 36:135-144.
17. Ballard C., Neill D., O'Brien J., McKeith I.G., Ince P., Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J. Affect. Disord. 2000, 59:97-106.
18. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 2008, 57:531-553.
19. Basser P.J., Mattiello J., LeBihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. B 1994, 103:247-254.
20. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 1994, 66:259-267.
21. Berman M.G., Peltier S., Nee D.E., Kross E., Deldin P.J., Jonides J. Depression, rumination and the default network. Soc. Cogn. Affect. Neurosci. 2010.
22. Binder E.B., Owens M.J., Liu W., Deveau T.C., Rush A.J., Trivedi M.H., Fava M., Bradley B., Ressler K.J., Nemeroff C.B. Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response. Arch. Gen. Psychiatry 2010, 67:369-379.
23. Binder E.B., Salyakina D., Lichtner P., Wochnik G.M., Ising M., Putz B., Papiol S., Seaman S., Lucae S., Kohli M.A., Nickel T., Kunzel H.E., Fuchs B., Majer M., Pfennig A., Kern N., Brunner J., Modell S., Baghai T., Deiml T., Zill P., Bondy B., Rupprecht R., Messer T., Kohnlein O., Dabitz H., Bruckl T., Muller N., Pfister H., Lieb R., Mueller J.C., Lohmussaar E., Strom T.M., Bettecken T., Meitinger T., Uhr M., Rein T., Holsboer F., Muller-Myhsok B. Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat. Genet. 2004, 36:1319-1325.
24. Blasko I., Lederer W., Oberbauer H., Walch T., Kemmler G., Hinterhuber H., Marksteiner J., Humpel C. Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias. Dement. Geriatr. Cogn. Disord. 2006, 21:9-15.
25. Blennow K. Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 2004, 1:213-225.
26. Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 2010, 6:131-144.
27. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?. Mol. Chem. Neuropathol. 1995, 26:231-245.
28. Bokde A.L., Ewers M., Hampel H. Assessing neuronal networks: understanding Alzheimer's disease. Prog. Neurobiol. 2009, 89:125-133.
29. Brambilla P., Stanley J.A., Nicoletti M.A., Sassi R.B., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., Soares J.C. 1H Magnetic resonance spectroscopy study of dorsolateral prefrontal cortex in unipolar mood disorder patients. Psychiatry Res. 2005, 138:131-139.
30. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am. J. Psychiatry 2000, 157:115-118.
31. Brouwer J.P., Appelhof B.C., van Rossum E.F., Koper J.W., Fliers E., Huyser J., Schene A.H., Tijssen J.G., Van D.R., Lamberts S.W., Wiersinga W.M., Hoogendijk W.J. Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression. Psychoneuroendocrinology 2006, 31:1154-1163.
32. Brown G.G., Perthen J.E., Liu T.T., Buxton R.B. A primer on functional magnetic resonance imaging. Neuropsychol. Rev. 2007, 17:107-125.
33. Brunoni A.R., Lopes M., Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 2008, 11:1169-1180.
34. Buckner R.L., Snyder A.Z., Shannon B.J., LaRossa G., Sachs R., Fotenos A.F., Sheline Y.I., Klunk W.E., Mathis C.A., Morris J.C., Mintun M.A. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 2005, 25:7709-7717.
35. Bürger née Buch K., Padberg F., Nolde T., Teipel S.J., Stubner S., Haslinger A., Schwarz M.J., Sunderland T., Arai H., Rapoport S.I., Moller H.J., Hampel H. Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls. Neurosci. Lett. 1999, 277:21-24.
36. Caetano S.C., Hatch J.P., Brambilla P., Sassi R.B., Nicoletti M., Mallinger A.G., Frank E., Kupfer D.J., Keshavan M.S., Soares J.C. Anatomical MRI study of hippocampus and amygdala in patients with current and remitted major depression. Psychiatry Res. 2004, 132:141-147.
37. Cameron H.A., Gould E. Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience 1994, 61:203-209.
38. Canli T., Qiu M., Omura K., Congdon E., Haas B.W., Amin Z., Herrmann M.J., Constable R.T., Lesch K.P. Neural correlates of epigenesis. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16033-16038.
39. Capizzano A.A., Jorge R.E., Acion L.C., Robinson R.G. In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review. J. Magn. Reson. Imaging 2007, 26:1378-1389.
40. Caruncho H.J., Rivera-Baltanas T. Biomarkers of depression. Rev. Neurol. 2010, 50:470-476.
41. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., Poulton R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301:386-389.
42. Cecil K.M., Delbello M.P., Morey R., Strakowski S.M. Frontal lobe differences in bipolar disorder as determined by proton MR spectroscopy. Bipolar Disord. 2002, 4:357-365.
43. Cerullo M.A., Adler C.M., Delbello M.P., Strakowski S.M. The functional neuroanatomy of bipolar disorder. Int. Rev. Psychiatry 2009, 21:314-322.
44. Colliot O., Chetelat G., Chupin M., Desgranges B., Magnin B., Benali H., Dubois B., Garnero L., Eustache F., Lehericy S. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 2008, 248:194-201.
45. Craig-Schapiro R., Kuhn M., Xiong C., Pickering E.H., Liu J., Misko T.P., Perrin R.J., Bales K.R., Soares H., Fagan A.M., Holtzman D.M. Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS One 2011, 6:e18850.
46. Cyranowski J.M., Hofkens T.L., Frank E., Seltman H., Cai H.M., Amico J.A. Evidence of dysregulated peripheral oxytocin release among depressed women. Psychosom. Med. 2008, 70:967-975.
47. Dager S.R., Friedman S.D., Parow A., Demopulos C., Stoll A.L., Lyoo I.K., Dunner D.L., Renshaw P.F. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch. Gen. Psychiatry 2004, 61:450-458.
48. Dannlowski U., Ohrmann P., Konrad C., Domschke K., Bauer J., Kugel H., Hohoff C., Schoning S., Kersting A., Baune B.T., Mortensen L.S., Arolt V., Zwitserlood P., Deckert J., Heindel W., Suslow T. Reduced amygdala-prefrontal coupling in major depression: association with MAOA genotype and illness severity. Int. J. Neuropsychopharmacol. 2009, 12:11-22.
49. de Winter R.F., van Hemert A.M., DeRijk R.H., Zwinderman K.H., Frankhuijzen-Sierevogel A.C., Wiegant V.M., Goekoop J.G. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 2003, 28:140-147.
50. Dias V.V., Brissos S., Frey B.N., Andreazza A.C., Cardoso C., Kapczinski F. Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder. Bipolar Disord. 2009, 11:663-671.
51. Dias-Ferreira E., Sousa J.C., Melo I., Morgado P., Mesquita A.R., Cerqueira J.J., Costa R.M., Sousa N. Chronic stress causes frontostriatal reorganization and affects decision-making. Science 2009, 325:621-625.
52. Dichter G.S., Felder J.N., Petty C., Bizzell J., Ernst M., Smoski M.J. The effects of psychotherapy on neural responses to rewards in major depression. Biol. Psychiatry 2009, 66:886-897.
53. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 2001, 11:240-249.
54. Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 2007, 34:865-877.
55. Duman R.S., Vaidya V.A. Molecular and cellular actions of chronic electroconvulsive seizures. J. ECT 1998, 14:181-193.
56. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
57. Erk S., Mikschl A., Stier S., Ciaramidaro A., Gapp V., Weber B., Walter H. Acute and sustained effects of cognitive emotion regulation in major depression. J. Neurosci. 2010, 30:15726-15734.
58. Falagas M.E., Vardakas K.Z., Vergidis P.I. Under-diagnosis of common chronic diseases: prevalence and impact on human health. Int. J. Clin. Pract. 2007, 61:1569-1579.
59. Förstl H., Burns A., Luthert P., Cairns N., Lantos P., Levy R. Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol. Med. 1992, 22:877-884.
60. Frodl T., Bokde A.L., Scheuerecker J., Lisiecka D., Schoepf V., Hampel H., Moller H.J., Bruckmann H., Wiesmann M., Meisenzahl E. Functional connectivity bias of the orbitofrontal cortex in drug-free patients with major depression. Biol. Psychiatry 2010, 67:161-167.
61. Frodl T., Jäger M., Smajstrlova I., Born C., Bottlender R., Palladino T., Reiser M., Moller H.J., Meisenzahl E.M. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J. Psychiatry Neurosci. 2008, 33:423-430.
62. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Jager M., Groll C., Bottlender R., Leinsinger G., Moller H.J. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol. Psychiatry 2003, 53:338-344.
63. Frodl T., Möller H.J., Meisenzahl E. Neuroimaging genetics: new perspectives in research on major depression?. Acta Psychiatr. Scand. 2008, 118:363-372.
64. Frodl T., Schule C., Schmitt G., Born C., Baghai T., Zill P., Bottlender R., Rupprecht R., Bondy B., Reiser M., Moller H.J., Meisenzahl E.M. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch. Gen. Psychiatry 2007, 64:410-416.
65. Frodl T., Stauber J., Schaaff N., Koutsouleris N., Scheuerecker J., Ewers M., Omerovic M., Opgen-Rhein M., Hampel H., Reiser M., Moller H.J., Meisenzahl E. Amygdala reduction in patients with ADHD compared with major depression and healthy volunteers. Acta Psychiatr. Scand. 2010, 121:111-118.
66. Garcia C., Chen M.J., Garza A.A., Cotman C.W., Russo-Neustadt A. The influence of specific noradrenergic and serotonergic lesions on the expression of hippocampal brain-derived neurotrophic factor transcripts following voluntary physical activity. Neuroscience 2003, 119:721-732.
67. Garcia R. Stress, metaplasticity, and antidepressants. Curr. Mol. Med. 2002, 2:629-638.
68. Gerardin E., Chetelat G., Chupin M., Cuingnet R., Desgranges B., Kim H.S., Niethammer M., Dubois B., Lehericy S., Garnero L., Eustache F., Colliot O. Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging. Neuroimage 2009, 47:1476-1486.
69. Gervasoni N., Aubry J.M., Bondolfi G., Osiek C., Schwald M., Bertschy G., Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005, 51:234-238.
70. Gonul A.S., Akdeniz F., Taneli F., Donat O., Eker C., Vahip S. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 2005, 255:381-386.
71. Goodyer I.M., Croudace T., Dudbridge F., Ban M., Herbert J. Polymorphisms in BDNF (Val66Met) and 5-HTTLPR, morning cortisol and subsequent depression in at-risk adolescents. Br. J. Psychiatry 2010, 197:365-371.
72. Gotlib I.H., Sivers H., Gabrieli J.D., Whitfield-Gabrieli S., Goldin P., Minor K.L., Canli T. Subgenual anterior cingulate activation to valenced emotional stimuli in major depression. Neuroreport 2005, 16:1731-1734.
73. Greicius M.D., Flores B.H., Menon V., Glover G.H., Solvason H.B., Kenna H., Reiss A.L., Schatzberg A.F. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol. Psychiatry 2007, 62:429-437.
74. Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69:89-95.
75. Gruber S., Frey R., Mlynarik V., Stadlbauer A., Heiden A., Kasper S., Kemp G.J., Moser E. Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H-MRS at 3 Tesla. Invest. Radiol. 2003, 38:403-408.
76. Guze B.H., Baxter L.R., Schwartz J.M., Szuba M.P., Mazziotta J.C., Phelps M.E. Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report. Psychiatry Res. 1991, 40:195-202.
77. Hampel H., Buerger K., Zinkowski R., Teipel S.J., Goernitz A., Andreasen N., Sjoegren M., DeBernardis J., Kerkman D., Ishiguro K., Ohno H., Vanmechelen E., Vanderstichele H., McCulloch C., Möller H.J., Davies P., Blennow K. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Arch. Gen. Psychiatry 2004, 61:95-102.
78. Hampel H., Frank R., Broich K., Teipel S.J., Katz R.G., Hardy J., Herholz K., Bokde A.L., Jessen F., Hoessler Y.C., Sanhai W.R., Zetterberg H., Woodcock J., Blennow K. Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Discov. 2010, 9:560-574.
79. Hampel H., Kotter H.U., Möller H.J. Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets. Alzheimer Dis. Assoc. Disord. 1997, 11:78-87.
80. Hampel H., Kotter H.U., Padberg F., Korschenhausen D.A., Möller H.J. Oligoclonal bands and blood-cerebrospinal-fluid barrier dysfunction in a subset of patients with Alzheimer disease: comparison with vascular dementia, major depression, and multiple sclerosis. Alzheimer Dis. Assoc. Disord. 1999, 13:9-19.
81. Hampel H., Shen Y., Walsh D.M., Aisen P., Shaw L.M., Zetterberg H., Trojanowski J.Q., Blennow K. Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp. Neurol. 2010, 223:334-346.
82. Hampel H., Teipel S.J., Padberg F., Haslinger A., Riemenschneider M., Schwarz M.J., Kotter H.U., Scheloske M., Buch K., Stubner S., Dukoff R., Lasser R., Müller N., Sunderland T., Rapoport S.I., Möller H.J. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Res. 1999, 823:104-112.
83. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006, 5:228-234.
84. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin. Neurosci. 2010, 64:341-357.
85. Hastings R.S., Parsey R.V., Oquendo M.A., Arango V., Mann J.J. Volumetric analysis of the prefrontal cortex, amygdala, and hippocampus in major depression. Neuropsychopharmacology 2004, 29:952-959.
86. Hedden T., Van Dijk K.R., Becker J.A., Mehta A., Sperling R.A., Johnson K.A., Buckner R.L. Disruption of functional connectivity in clinically normal older adults harboring amyloid burden. J. Neurosci. 2009, 29:12686-12694.
87. Hernandez-Garcia L. Arterial spin labeling for quantitative functional MRI. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2004, 7:5230-5233.
88. Heuser I., Yassouridis A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J. Psychiatr. Res. 1994, 28:341-356.
89. Heuser I.J., Schweiger U., Gotthardt U., Schmider J., Lammers C.H., Dettling M., Yassouridis A., Holsboer F. Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry 1996, 153:93-99.
90. Hirvonen J., Karlsson H., Kajander J., Lepola A., Markkula J., Rasi-Hakala H., Nagren K., Salminen J.K., Hietala J. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int. J. Neuropsychopharmacol. 2008, 11:465-476.
91. Holsboer F., Gerken A., Stalla G.K., Muller O.A. Blunted aldosterone and ACTH release after human CRH administration in depressed patients. Am. J. Psychiatry 1987, 144:229-231.
92. Holsboer F., von Bardeleben U., Buller R., Heuser I., Steiger A. Stimulation response to corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm. Metab. Res. Suppl. 1987, 16:80-88.
93. Holsboer-Trachsler E., Buol C., Wiedemann K., Holsboer F. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels. Acta Psychiatr. Scand. 1987, 75:608-613.
94. Holsboer-Trachsler E., Stohler R., Hatzinger M. Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry Res. 1991, 38:163-171.
95. Horn R., Ostertun B., Fric M., Solymosi L., Steudel A., Moller H.J. Atrophy of hippocampus in patients with Alzheimer's disease and other diseases with memory impairment. Dementia 1996, 7:182-186.
96. Inder W.J., Donald R.A., Prickett T.C., Frampton C.M., Sullivan P.F., Mulder R.T., Joyce P.R. Arginine vasopressin is associated with hypercortisolemia and suicide attempts in depression. Biol. Psychiatry 1997, 42:744-747.
97. Jacobs B.L., van Praag H., Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 2000, 5:262-269.
98. Johnstone T., van Reekum C.M., Urry H.L., Kalin N.H., Davidson R.J. Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. J. Neurosci. 2007, 27:8877-8884.
99. Jorm A.F. History of depression as a risk factor for dementia: an updated review. Aust. N.Z. J. Psychiatry 2001, 35:776-781.
100. Kanellopoulos D., Gunning F.M., Morimoto S.S., Hoptman M.J., Murphy C.F., Kelly R.E., Glatt C., Lim K.O., Alexopoulos G.S. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. Am. J. Geriatr. Psychiatry 2011, 19:13-22.
101. Kantarci K. 1H magnetic resonance spectroscopy in dementia. Br. J. Radiol. 2007, S146-S152. 80 Spec No. 2.
102. Karg K., Burmeister M., Shedden K., Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch. Gen. Psychiatry 2011.
103. Keller J., Shen L., Gomez R.G., Garrett A., Solvason H.B., Reiss A., Schatzberg A.F. Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression. Am. J. Psychiatry 2008, 165:872-880.
104. Kim J.J., Pae C.U., Kim M.R., Min J.A., Kim K.H., Lee C.U., Lee C., Paik I.H. Association between estrogen receptor gene polymorphisms and depression in post-menopausal women: a preliminary study. Psychiatry Investig. 2010, 7:224-227.
105. Koch J.M., Hinze-Selch D., Stingele K., Huchzermeier C., Goder R., Seeck-Hirschner M., Aldenhoff J.B. Changes in CREB phosphorylation and BDNF plasma levels during psychotherapy of depression. Psychother. Psychosom. 2009, 78:187-192.
106. Koch W., Teipel S., Mueller S., Buerger K., Bokde A.L., Hampel H., Coates U., Reiser M., Meindl T. Effects of aging on default mode network activity in resting state fMRI: does the method of analysis matter?. Neuroimage 2010, 51:280-287.
107. Kokmen E. The EURODEM collaborative re-analysis of case-control studies of Alzheimer's disease: implications for clinical research and practice. Int. J. Epidemiol. 1991, 20(Suppl. 2):S65-S67.
108. Koolschijn P.C., van Haren N.E., Lensvelt-Mulders G.J., Hulshoff Pol H.E., Kahn R.S. Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum. Brain Mapp. 2009, 30:3719-3735.
109. Kronenberg G., Tebartz van E.L., Regen F., Deuschle M., Heuser I., Colla M. Reduced amygdala volume in newly admitted psychiatric in-patients with unipolar major depression. J. Psychiatr. Res. 2009, 43:1112-1117.
110. Kuhl D.E., Metter E.J., Riege W.H. Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 1985, 63:211-226.
111. Kumar A., Newberg A., Alavi A., Berlin J., Smith R., Reivich M. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:7019-7023.
112. Lange C., Irle E. Enlarged amygdala volume and reduced hippocampal volume in young women with major depression. Psychol. Med. 2004, 34:1059-1064.
113. Laske C., Stransky E., Fritsche A., Eschweiler G.W., Leyhe T. Inverse association of cortisol serum levels with T-tau, P-tau 181 and P-tau 231 peptide levels and T-tau/Abeta 1-42 ratios in CSF in patients with mild Alzheimer's disease dementia. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259:80-85.
114. Laske C., Stransky E., Leyhe T., Eschweiler G.W., Maetzler W., Wittorf A., Soekadar S., Richartz E., Koehler N., Bartels M., Buchkremer G., Schott K. BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J. Psychiatr. Res. 2007, 41:387-394.
115. Laske C., Stransky E., Leyhe T., Eschweiler G.W., Wittorf A., Richartz E., Bartels M., Buchkremer G., Schott K. Stage-dependent BDNF serum concentrations in Alzheimer's disease. J. Neural Transm. 2006, 113:1217-1224.
116. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G.B., McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 2002, 156:445-453.
117. Liu Z., Zhu F., Wang G., Xiao Z., Wang H., Tang J., Wang X., Qiu D., Liu W., Cao Z., Li W. Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression. Neurosci. Lett. 2006, 404:358-362.
118. Logothetis N.K. The neural basis of the blood-oxygen-level-dependent functional magnetic resonance imaging signal. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2002, 357:1003-1037.
119. Lorenzetti V., Allen N.B., Fornito A., Yucel M. Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies. J. Affect. Disord. 2009, 117:1-17.
120. Luborzewski A., Schubert F., Seifert F., Danker-Hopfe H., Brakemeier E.L., Schlattmann P., Anghelescu I., Colla M., Bajbouj M. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J. Psychiatr. Res. 2007, 41:606-615.
121. Lundquist R.S., Bernens A., Olsen C.G. Comorbid disease in geriatric patients: dementia and depression. Am. Fam. Physician 1997, 55:2687-2694.
122. Lyketsos C.G., Olin J. Depression in Alzheimer's disease: overview and treatment. Biol. Psychiatry 2002, 52:243-252.
123. Lyketsos C.G., Steinberg M., Tschanz J.T., Norton M.C., Steffens D.C., Breitner J.C. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am. J. Psychiatry 2000, 157:708-714.
124. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 1995, 15:7929-7939.
125. Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008, 33:73-83.
126. Matthews S.C., Strigo I.A., Simmons A.N., Yang T.T., Paulus M.P. Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J. Affect. Disord. 2008, 111:13-20.
127. Mattson M.P., Maudsley S., Martin B. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 2004, 27:589-594.
128. Mattsson N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., Herukka S.K., van der Flier W.M., Blankenstein M.A., Ewers M., Rich K., Kaiser E., Verbeek M., Tsolaki M., Mulugeta E., Rosen E., Aarsland D., Visser P.J., Schroder J., Marcusson J., de L.M., Hampel H., Scheltens P., Pirttila T., Wallin A., Jonhagen M.E., Minthon L., Winblad B., Blennow K. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009, 302:385-393.
129. Mayberg H.S., Brannan S.K., Mahurin R.K., Jerabek P.A., Brickman J.S., Tekell J.L., Silva J.A., McGinnis S., Glass T.G., Martin C.C., Fox P.T. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997, 8:1057-1061.
130. McCulley M.C., Day I.N., Holmes C. Association between interleukin 1-beta promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2004, 124B:50-53.
131. McEwen B.S., Magarinos A.M. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum. Psychopharmacol. 2001, 16:S7-S19.
132. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
133. Meisenzahl E.M., Seifert D., Bottlender R., Teipel S., Zetzsche T., Jager M., Koutsouleris N., Schmitt G., Scheuerecker J., Burgermeister B., Hampel H., Rupprecht T., Born C., Reiser M., Moller H.J., Frodl T. Differences in hippocampal volume between major depression and schizophrenia: a comparative neuroimaging study. Eur. Arch. Psychiatry Clin. Neurosci. 2010, 260:127-137.
134. Meltzer C.C., Price J.C., Mathis C.A., Butters M.A., Ziolko S.K., Moses-Kolko E., Mazumdar S., Mulsant B.H., Houck P.R., Lopresti B.J., Weissfeld L.A., Reynolds C.F. Serotonin 1A receptor binding and treatment response in late-life depression. Neuropsychopharmacology 2004, 29:2258-2265.
135. Meynen G., Unmehopa U.A., Hofman M.A., Swaab D.F., Hoogendijk W.J. Hypothalamic oxytocin mRNA expression and melancholic depression. Mol. Psychiatry 2007, 12:118-119.
136. Meynen G., Unmehopa U.A., van Heerikhuize J.J., Hofman M.A., Swaab D.F., Hoogendijk W.J. Increased arginine vasopressin mRNA expression in the human hypothalamus in depression: a preliminary report1. Biol. Psychiatry 2006, 60:892-895.
137. Michael N., Erfurth A., Ohrmann P., Arolt V., Heindel W., Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol. Med. 2003, 33:1277-1284.
138. Mirza Y., Tang J., Russell A., Banerjee S.P., Bhandari R., Ivey J., Rose M., Moore G.J., Rosenberg D.R. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:341-348.
139. Modell S., Yassouridis A., Huber J., Holsboer F. Corticosteroid receptor function is decreased in depressed patients. Neuroendocrinology 1997, 65:216-222.
140. Monkul E.S., Hatch J.P., Nicoletti M.A., Spence S., Brambilla P., Lacerda A.L., Sassi R.B., Mallinger A.G., Keshavan M.S., Soares J.C. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol. Psychiatry 2007, 12:360-366.
141. Morys J.M., Bobek-Billewicz B., Dziewiatkowski J., Ratajczak I., Pankiewicz P., Narkiewicz O., Morys J. A magnetic resonance volumetric study of the temporal lobe structures in depression. Folia Morphol. (Warsz) 2003, 62:347-352.
142. Moses-Kolko E.L., Wisner K.L., Price J.C., Berga S.L., Drevets W.C., Hanusa B.H., Loucks T.L., Meltzer C.C. Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study. Fertil. Steril. 2008, 89:685-692.
143. Mössner R., Mikova O., Koutsilieri E., Saoud M., Ehlis A.C., Muller N., Fallgatter A.J., Riederer P. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J. Biol. Psychiatry 2007, 8:141-174.
144. Müller M.B., Toschi N., Kresse A.E., Post A., Keck M.E. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology 2000, 23:205-215.
145. Munn M.A., Alexopoulos J., Nishino T., Babb C.M., Flake L.A., Singer T., Ratnanather J.T., Huang H., Todd R.D., Miller M.I., Botteron K.N. Amygdala volume analysis in female twins with major depression. Biol. Psychiatry 2007, 62:415-422.
146. Murphy B.E. Steroids and depression. J. Steroid Biochem. Mol. Biol. 1991, 38:537-559.
147. Nelson J.C., Davis J.M. DST studies in psychotic depression: a meta-analysis. Am. J. Psychiatry 1997, 154:1497-1503.
148. Neumeister A., Drevets W.C., Belfer I., Luckenbaugh D.A., Henry S., Bonne O., Herscovitch P., Goldman D., Charney D.S. Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression. Neuropsychopharmacology 2006, 31:1750-1756.
149. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 1995, 15:7539-7547.
150. O'Brien J.T., Desmond P., Ames D., Schweitzer I., Tuckwell V., Tress B. The differentiation of depression from dementia by temporal lobe magnetic resonance imaging. Psychol. Med. 1994, 24:633-640.
151. Oliff H.S., Berchtold N.C., Isackson P., Cotman C.W. Exercise-induced regulation of brain-derived neurotrophic factor (BDNF) transcripts in the rat hippocampus. Brain Res. Mol. Brain Res. 1998, 61:147-153.
152. Olin J.T., Katz I.R., Meyers B.S., Schneider L.S., Lebowitz B.D. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. Am. J. Geriatr. Psychiatry 2002, 10:129-141.
153. Pantel J., Schroder J., Essig M., Popp D., Dech H., Knopp M.V., Schad L.R., Eysenbach K., Backenstrass M., Friedlinger M. Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia. J. Affect. Disord. 1997, 42:69-83.
154. Panza F., Frisardi V., Capurso C., D'Introno A., Colacicco A.M., Imbimbo B.P., Santamato A., Vendemiale G., Seripa D., Pilotto A., Capurso A., Solfrizzi V. Late-life depression, mild cognitive impairment, and dementia: possible continuum?. Am. J. Geriatr. Psychiatry 2010, 18:98-116.
155. Park J.H., Lee S.B., Lee T.J., Lee D.Y., Jhoo J.H., Youn J.C., Choo I.H., Choi E.A., Jeong J.W., Choe J.Y., Woo J.I., Kim K.W. Depression in vascular dementia is quantitatively and qualitatively different from depression in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2007, 23:67-73.
156. Parker K.J., Kenna H.A., Zeitzer J.M., Keller J., Blasey C.M., Amico J.A., Schatzberg A.F. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res. 2010, 178:359-362.
157. Pettmann B., Henderson C.E. Neuronal cell death. Neuron 1998, 20:633-647.
158. Pfleiderer B., Michael N., Erfurth A., Ohrmann P., Hohmann U., Wolgast M., Fiebich M., Arolt V., Heindel W. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 2003, 122:185-192.
159. Pierpaoli C., Jezzard P., Basser P.J., Barnett A., Di C.G. Diffusion tensor MR imaging of the human brain. Radiology 1996, 201:637-648.
160. Pizzagalli D.A. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology 2011, 36:183-206.
161. Pizzagalli D.A., Oakes T.R., Fox A.S., Chung M.K., Larson C.L., Abercrombie H.C., Schaefer S.M., Benca R.M., Davidson R.J. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol. Psychiatry 2004, 9(325). pp. 393-325, 405.
162. Post A., Ackl N., Rucker M., Schreiber Y., Binder E.B., Ising M., Sonntag A., Holsboer F., Almeida O.F. Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-type dementia versus major depression. Biol. Psychiatry 2006, 59:858-862.
163. Praschak-Rieder N., Willeit M., Wilson A.A., Houle S., Meyer J.H. Seasonal variation in human brain serotonin transporter binding. Arch. Gen. Psychiatry 2008, 65:1072-1078.
164. Raichle M.E., MacLeod A.M., Snyder A.Z., Powers W.J., Gusnard D.A., Shulman G.L. A default mode of brain function. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:676-682.
165. Rasmuson S., Nasman B., Carlstrom K., Olsson T. Increased levels of adrenocortical and gonadal hormones in mild to moderate Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 2002, 13:74-79.
166. Rasmuson S., Nasman B., Eriksson S., Carlstrom K., Olsson T. Adrenal responsivity in normal aging and mild to moderate Alzheimer's disease. Biol. Psychiatry 1998, 43:401-407.
167. Ritsner M.S., Gottesman I.I. Where do we stand in the quest for neuropsychiatric biomarkers and what next?. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes 2009, Springer, New York, (Chapter 1), pp. 3-17.
168. Robbins T.W., Elliott R., Sahakian B.J. Neuropsychology-dementia and affective disorders. Br. Med. Bull. 1996, 52:627-643.
169. Roffman J.L., Marci C.D., Glick D.M., Dougherty D.D., Rauch S.L. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol. Med. 2005, 35:1385-1398.
170. Rosenberg D.R., Mirza Y., Russell A., Tang J., Smith J.M., Banerjee S.P., Bhandari R., Rose M., Ivey J., Boyd C., Moore G.J. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43:1146-1153.
171. Rosso I.M., Cintron C.M., Steingard R.J., Renshaw P.F., Young A.D., Yurgelun-Todd D.A. Amygdala and hippocampus volumes in pediatric major depression. Biol. Psychiatry 2005, 57:21-26.
172. Roy A., Pickar D., Paul S., Doran A., Chrousos G.P., Gold P.W. CSF corticotropin-releasing hormone in depressed patients and normal control subjects. Am. J. Psychiatry 1987, 144:641-645.
173. Rüb U., Del T.K., Schultz C., Thal D.R., Braak E., Braak H. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol. Appl. Neurobiol. 2000, 26:553-567.
174. Salmon E., Perani D., Herholz K., Marique P., Kalbe E., Holthoff V., Delbeuck X., Beuthien-Baumann B., Pelati O., Lespagnard S., Collette F., Garraux G. Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease. Hum. Brain Mapp. 2006, 27:588-597.
175. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.T., Appel M., Rothman D.L., Krystal J.H., Mason G.F. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch. Gen. Psychiatry 2004, 61:705-713.
176. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., Berman R.M., Charney D.S., Krystal J.H. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 1999, 56:1043-1047.
177. Savitz J., Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci. Biobehav. Rev. 2009, 33:699-771.
178. Scantamburlo G., Hansenne M., Fuchs S., Pitchot W., Marechal P., Pequeux C., Ansseau M., Legros J.J. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 2007, 32:407-410.
179. Schumacher J., Jamra R.A., Becker T., Ohlraun S., Klopp N., Binder E.B., Schulze T.G., Deschner M., Schmal C., Hofels S., Zobel A., Illig T., Propping P., Holsboer F., Rietschel M., Nothen M.M., Cichon S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005, 58:307-314.
180. Sen S., Duman R., Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 2008, 64:527-532.
181. Sexton C.E., Mackay C.E., Ebmeier K.P. A systematic review of diffusion tensor imaging studies in affective disorders. Biol. Psychiatry 2009, 66:814-823.
182. Sheline Y.I., Price J.L., Yan Z., Mintun M.A. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11020-11025.
183. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neurosci. 1999, 19:5034-5043.
184. Sjögren M., Minthon L., Davidsson P., Granerus A.-K., Clarberg A., Vanderstichele H., Vanmechelen E., Wallin A., Blennow K. CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging. J. Neural Transm. 2000, 107:563-579.
185. Sousa N., Cerqueira J.J., Almeida O.F. Corticosteroid receptors and neuroplasticity. Brain Res. Rev. 2008, 57:561-570.
186. Sousa N., Lukoyanov N.V., Madeira M.D., Almeida O.F., Paula-Barbosa M.M. Reorganization of the morphology of hippocampal neurites and synapses after stress-induced damage correlates with behavioral improvement. Neuroscience 2000, 97:253-266.
187. Speck C.E., Kukull W.A., Brenner D.E., Bowen J.D., McCormick W.C., Teri L., Pfanschmidt M.L., Thompson J.D., Larson E.B. History of depression as a risk factor for Alzheimer's disease. Epidemiology 1995, 6:366-369.
188. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:280-292.
189. Spijker A.T., van Rossum E.F. Glucocorticoid receptor polymorphisms in major depression. Focus on glucocorticoid sensitivity and neurocognitive functioning. Ann. N.Y. Acad. Sci. 2009, 1179:199-215.
190. Starkstein S.E., Mizrahi R., Power B.D. Depression in Alzheimer's disease: phenomenology, clinical correlates and treatment. Int. Rev. Psychiatry 2008, 20:382-388.
191. Taylor W.D., MacFall J.R., Boyd B., Payne M.E., Sheline Y.I., Krishnan R.R., Murali D.P. One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes. Am. J. Geriatr. Psychiatry 2011, 19:43-52.
192. Teipel S.J., Ewers M., Wolf S., Jessen F., Kolsch H., Arlt S., Luckhaus C., Schonknecht P., Schmidtke K., Heuser I., Frolich L., Ende G., Pantel J., Wiltfang J., Rakebrandt F., Peters O., Born C., Kornhuber J., Hampel H. Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease. Psychiatry Res. 2010, 182:244-250.
193. Thomason M.E., Yoo D.J., Glover G.H., Gotlib I.H. BDNF genotype modulates resting functional connectivity in children. Front. Hum. Neurosci. 2009, 3:55.
194. Tsolaki M., Fountoulakis K., Chantzi E., Kazis A. Risk factors for clinically diagnosed Alzheimer's disease: a case-control study of a Greek population. Int. Psychogeriatr. 1997, 9:327-341.
195. Usman S., Chaudhary H.R., Asif A., Yahya M.I. Severity and risk factors of depression in Alzheimer's disease. J. Coll. Physicians Surg. Pak. 2010, 20:327-330.
196. van Londen L., Goekoop J.G., van Kempen G.M., Frankhuijzen-Sierevogel A.C., Wiegant V.M., van der Velde E.A., De W.D. Plasma levels of arginine vasopressin elevated in patients with major depression. Neuropsychopharmacology 1997, 17:284-292.
197. van Praag H.M. Can stress cause depression?. World J. Biol. Psychiatry 2005, 6(Suppl. 2):5-22.
198. Videbech P., Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161:1957-1966.
199. Villafuerte S.M., Del-Favero J., Adolfsson R., Souery D., Massat I., Mendlewicz J., Van B.C., Claes S. Gene-based SNP genetic association study of the corticotropin-releasing hormone receptor-2 (CRHR2) in major depression. Am. J. Med. Genet. 2002, 114:222-226.
200. Viswanathan A., Freeman R.D. Neurometabolic coupling in cerebral cortex reflects synaptic more than spiking activity. Nat. Neurosci. 2007, 10:1308-1312.
201. Walter M., Henning A., Grimm S., Schulte R.F., Beck J., Dydak U., Schnepf B., Boeker H., Boesiger P., Northoff G. The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. Arch. Gen. Psychiatry 2009, 66:478-486.
202. Wells T.T., Beevers C.G., McGeary J.E. Serotonin transporter and BDNF genetic variants interact to predict cognitive reactivity in healthy adults. J. Affect. Disord. 2010, 126:223-229.
203. Weniger G., Lange C., Irle E. Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder. J. Affect. Disord. 2006, 94:219-229.
204. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol. Rev. 1991, 43:553-561.
205. Williams D.R., Gonzalez H.M., Neighbors H., Nesse R., Abelson J.M., Sweetman J., Jackson J.S. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch. Gen. Psychiatry 2007, 64:305-315.
206. Wu J., Buchsbaum M.S., Gillin J.C., Tang C., Cadwell S., Wiegand M., Najafi A., Klein E., Hazen K., Bunney W.E., Fallon J.H., Keator D. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am. J. Psychiatry 1999, 156:1149-1158.
207. Yamada K., Nabeshima T. Brain-derived neurotrophic factor/TrkB signaling in memory processes. J. Pharmacol. Sci. 2003, 91:267-270.
208. Yasutake C., Kuroda K., Yanagawa T., Okamura T., Yoneda H. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. Eur. Arch. Psychiatry Clin. Neurosci. 2006, 256:402-406.
209. Yesavage J. Differential diagnosis between depression and dementia. Am. J. Med. 1993, 94:23S-28S.
210. Yulug B., Ozan E., Aydin N., Kirpinar I. Brain-derived neurotrophic factor polymorphism: more than a prognostic factor during depression?. J. Neuropsychiatry Clin. Neurosci. 2009, 21:471-472.
211. Zhu X., Wang X., Xiao J., Zhong M., Liao J., Yao S. Altered white matter integrity in first-episode, treatment-naive young adults with major depressive disorder: a tract-based spatial statistics study. Brain Res. 2011, 1369:223-229.
212. Zubenko G.S. Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology 1992, 6:77-93.
213. Zubenko G.S., Zubenko W.N., McPherson S., Spoor E., Marin D.B., Farlow M.R., Smith G.E., Geda Y.E., Cummings J.L., Petersen R.C., Sunderland T. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am. J. Psychiatry 2003, 160:857-866.